Anticoagulant effects of rivaroxaban, prednisone, alone and in combination, in healthy dogs

BACKGROUND: The potential effects of glucocorticoid administration on rivaroxaban's anticoagulant bioactivity in dogs, and an appropriate rivaroxaban dosage regimen for dogs receiving glucocorticoid therapy are unknown. HYPOTHESIS/OBJECTIVES: The objective was to determine whether glucocorticoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafner, Paige M., Mackin, Andrew J., Wills, Robert W., Brooks, Marjory B., Thomason, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708426/
https://www.ncbi.nlm.nih.gov/pubmed/36399000
http://dx.doi.org/10.1111/jvim.16572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708426/
https://www.ncbi.nlm.nih.gov/pubmed/36399000
http://dx.doi.org/10.1111/jvim.16572

Ejemplares similares